Anti-Factor XIIIa antibody [IHC572] (STJA0042166)
SPECIFICATIONS
ClonalityMonoclonal
HostRabbit
ConjugationUnconjugated
General Information
| Short Description | Rabbit monoclonal anti-Factor XIIIa for use in IHC-p in Human samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | IHC-p |
| Host | Rabbit |
| Reactivity | Human |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | IHC572 |
| Conjugation | Unconjugated |
| Formulation | Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide |
| Storage Instruction | Store at 2-8°C for up to 1 year. Do not freeze. |
Target Information
| Specificity | Tested and validated on placenta, dermatofibroma tissue. |
Additional Info
| Background | Factor XIIIa (FXIIIa) , also known as activated Factor XIII, is a blood coagulation factor that stabilizes fibrin and is present in monocytes, macrophages, platelets, megakaryocytes, dermal dendritic cells, and fibroblast-like mesenchymal or histiocytic cells in the placenta. Anti-Factor XIIIa is useful for distinguishing between dermatofibrosarcoma protuberans (±) , dermatofibroma (mostly +) , and desmoplastic malignant melanoma (-). Hemangioendothelioma, hemangiopericytoma, capillary hemagioblastoma, hepatocellular carcinoma, glomus tumour, xanthogranuloma, xanthoma, and meningioma all stain positively with Anti-Factor XIIIa. |
Information sourced from Uniprot.org